Age Related Macular Degeneration News and Research

RSS

Genetic mutation of APOE gene may provide protection against Alzheimer's disease

A team of researchers has identified that a genetic mutation of the APOE gene, the major susceptibility gene for late-onset Alzheimer's disease, may provide protection against the devastating neurological illness.

4 Nov 2019

Study pinpoints cell types linked to age-related macular degeneration

Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision.

25 Oct 2019

Ophthalmologists find more evidence linking common bladder drug to retinal conditions

A drug widely prescribed for a bladder condition for decades, now appears to be toxic to the retina, the light sensing tissue at the back of the eye that allows us to see.

14 Oct 2019

New gene therapy for wet age-related macular degeneration is on the horizon

Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks.

11 Oct 2019

Medical and surgical eye care experts gather in San Francisco for AAO 2019

More than 25,000 are expected to attend the American Academy of Ophthalmology's 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco.

11 Oct 2019

WHO’S first world report on vision

Vision is the most compelling contributor to the quality of our senses, and yet eye care lags behind many other areas in the importance it commands in public health. The World Health Organization (WHO) has said, in its report timed for World Sight Day (October 10), that over 2.2 billion people around the world (out of a total of 7.7 billion) are blind, completely or partially.

9 Oct 2019

Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina.

From Johns Hopkins Medicine 30 Sep 2019

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases.

From Boehringer Ingelheim International GmbH 25 Sep 2019

How older adults can make life easier and safer despite declining vision

The number of older Americans with low vision is expected to double in the coming years, as more people live longer.

24 Sep 2019

QUT researchers use deep learning methods for more accurate eye testing

Queensland University of Technology researchers have applied artificial intelligence deep learning techniques to develop a more accurate and detailed method for analyzing images of the back of the eye to help clinicians better detect and track eye diseases, such as glaucoma and age-related macular degeneration.

23 Sep 2019

New research suggests another possible mechanism for Alzheimer’s

Neurofibrillary plaques and tau protein are among the most widely known pathological entities characterizing Alzheimer’s disease (AD), but new research at the University of California, Riverside, has come up with another plausible explanation for this debilitating disorder.

13 Aug 2019

Scientists announce major breakthrough in understanding dry AMD

Scientists at Trinity College Dublin have announced a major breakthrough with important implications for sufferers of a common eye disease - dry Age-Related Macular Degeneration (AMD) - which can cause total blindness in sufferers, and for which there are currently no approved therapies.

8 Aug 2019

Reducing patient fears after dry AMD diagnosis

A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are diagnosed with the 'dry' form of age-related macular degeneration

29 Jun 2019

Complement system shown to remove dead cells in retinitis pigmentosa, contradicting previous research

Researchers have found that the complement system seems to protect against retinal degeneration in retinitis pigmentosa.

18 Jun 2019

New implant technology safely minimizes injections for people with macular degeneration

In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.

From Johns Hopkins Medicine 14 Jun 2019